Tafluprost Solution/ Drops
Product Images NDC 50742-339

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tafluprost (NDC 50742-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 01)

Chemical structure diagram of the active ingredient Tafluprost, showing molecular bonds, hydroxyl groups, fluorine atoms, and ester functional groups.*

FDA Label Image

Image (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 02)

FDA Label Image

Container Label (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 03)

Label for Tafluprost Ophthalmic Solution 0.0015% concentration. The label indicates it is prescription only (Rx only), manufactured for Ingenus Pharmaceuticals, LLC. The label includes a lot number and expiration date fields but they are not filled in.*

FDA Label Image

Pouch Label (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 04)

Label for Tafluprost Ophthalmic Solution 0.0015% (0.015 mg/mL) by Ingenus Pharmaceuticals, LLC. The label indicates a topical eye drop solution in preservative-free, sterile single-dose containers, with a package size of 5 containers, each 0.3 mL. Storage, usage instructions, inactive ingredients, and manufacturing details are included.*

FDA Label Image

Carton Label (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 05)

Packaging label for Tafluprost Ophthalmic Solution 0.0015%, an eye drop solution by Ingenus Pharmaceuticals, LLC. The label indicates it is for topical ophthalmic use, with 30 single-dose containers (6 pouches of 5 containers, 0.3 mL each). Storage is specified as refrigerate at 2° to 8°C or 36° to 46°F. The label includes active ingredient details, usage instructions, and shipping information, with the NDC 50742-339-30 clearly shown.*

FDA Label Image

Image (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 84 2)

Illustration showing a hand holding a single-dose ophthalmic solution drop container labeled as Figure A, demonstrating the container's size and how it is grasped between the thumb and forefinger.*

FDA Label Image

Image (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 84 3)

Illustration demonstrating how to remove or apply a component to an ophthalmic dropper bottle. The image shows two hands holding the dropper, with one hand gripping the bottle and the other pulling or adjusting the top part. The figure is labeled 'Figure B.'*

FDA Label Image

Image (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 84 4)

An instructional illustration showing a person administering ophthalmic solution drops into the eye using a dropper bottle. The image highlights the proper technique for instilling eye drops.*

FDA Label Image

Image (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 84 5)

An instructional illustration labeled Figure D shows a person applying eye drops. One hand holds the eye open, while the other hand administers a drop from a dropper into the eye, demonstrating proper ophthalmic solution use.*

FDA Label Image

Image (9ebbfaa4 B3c0 46d2 Bc83 9817b2d238df 84 6)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.